In this episode of the Orange Pill Podcast, we explore the evolving landscape of federal health agencies under the leadership of Secretary Robert Kennedy Jr. We’ll take a closer look at the potential reforms he aims to implement at the FDA and how these changes could impact the industry.
From Kennedy’s well-documented policy positions to recent initiatives by the Trump administration and the latest developments at HHS, we’re unpacking it all.
KGK Science has been delivering top-notch clinical research trials and expert regulatory support for the nutraceutical, cannabis, hemp, and psychedelic industries for over 27 years, aiding companies in bringing their products to global markets with custom trials and claim substantiation strategies.
Monday - Saturday 7:00 AM - 3:00 PM
